sorafenib has been researched along with salvianolic acid c in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (salvianolic acid c) | Trials (salvianolic acid c) | Recent Studies (post-2010) (salvianolic acid c) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 26 | 0 | 25 |
| Protein | Taxonomy | sorafenib (IC50) | salvianolic acid c (IC50) |
|---|---|---|---|
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 8.26 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 3.85 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Han, S; Jia, Q; Lin, Y; Lv, Y | 1 |
1 other study(ies) available for sorafenib and salvianolic acid c
| Article | Year |
|---|---|
Dual-mixed/CMC model for screening target components from traditional Chinese medicines simultaneously acting on EGFR & FGFR4 receptors.
Topics: Abietanes; Alkenes; Cell Proliferation; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; ErbB Receptors; Gefitinib; HEK293 Cells; Humans; Phenanthrenes; Polyphenols; Protein Kinase Inhibitors; Receptor, Fibroblast Growth Factor, Type 4; Salvia miltiorrhiza; Sorafenib; Spectrometry, Mass, Electrospray Ionization | 2019 |